Contrary to FDA, US Government supports mercury amalgam “phase down”

MPP recent wrote a letter supporting U.S. Government (USG) leadership calling for mercury amalgam “…phase down, with the goal of eventual phase out” in its most submission to the UN Mercury International Negotiating Committee (INC).  The USG position is consistent with WHO’s perspective as reflected in a presentation to INC1 and is also reflective of countries in the Nordic and elsewhere that have already phased down amalgam.  In addition, the letter urges the USG to not succumb to ADA’s recommendations to have FDA assume a leading role in the INC process, given that EPA, and not FDA has the expertise to address the global threat of mercury amalgam releases.